PRESENTATIONNATION

PRESENTATIONNATION

Browse a growing database of presentations shared by companies worldwide.

Browse

Browse All
All Companies
Presentations
Infographics
Reports
Brochures

Company

Blog
About
Contact

Legal

Privacy Policy
Terms of Service

© 2026 Presentation Nation. All rights reserved.
Built in San Diego by Twenty6 Red, Inc.

Criteo_July_2020_929_57929 - Criteo | Presentation Nation

HomepageCriteoCriteo_July_2020_929_57929

Criteo_July_2020_929_57929

Criteo

Browse presentations, reports, and documents from Criteo.

Tags

2020

Filter options

All (76)●
annual_report (6)○
brochure (29)○
earnings (3)○
infographic (1)○
investor_presentation (17)○
presentation (20)○

Get the best presentations in your inbox

Join professionals who get a weekly curated collection of top business presentations, investor decks, and industry reports — free.

No spam. Unsubscribe anytime.

Loading viewer...

investor_presentation

Format: PDF investor_presentation

Share:

This investor presentation outlines Criteo's Q2 2020 financial results, strategic priorities, and the impact of COVID-19 on its business.

Browse all investor_presentations →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from Criteo

2015_Convening_Notice_EN

annual_report

2015_Convening_Notice_FR

annual_report

2020+Brochure+French

Similar investor_presentations from other companies

Bird Construction Investor Presentation March 2021

investor_presentation

investor_presentation

28 Pages

Bird Construction

Aeterna Zentaris 2017 Investor Presentation

investor_presentation

annual_report

2022+Definitive+Proxy+Statement

brochure

2023+Definitive+Proxy+Statement

brochure

AGMCriteo_AvisConvocation_FR

annual_report

investor_presentation

33 Pages

Aeterna Zentaris

LifeMD__2023__124_94124

investor_presentation

LifeMD

Boralex Inc. January 2024 Investor Presentation

investor_presentation

investor_presentation

36 Pages

Boralex

Revance Therapeutics Investor Presentation — June 2020

investor_presentation

investor_presentation

34 Pages

Revance Therapeutics

Final_Analyst_Day_AVLR_2022

investor_presentation

Avalara